CEO Buys MAIA Shares After THIO‑104 Data: Insider Confidence & Life‑Science Outlook
Insider buying of MAIA Biotechnology shares signals confidence amid promising Phase 3 THIO‑104 data and global expansion—watch executive trades, payer deals, and tech adoption to gauge future growth.
4 minutes to read